Intracerebroventricular administration of okadaic acid induces hippocampal glucose uptake dysfunction and tau phosphorylation-Reference-Cited by-同舟云学术

Intracerebroventricular administration of okadaic acid induces hippocampal glucose uptake dysfunction and tau phosphorylation

Published:2016-06 Issue: Volume:124 Page:136-143
ISSN:0361-9230
Container-title:Brain Research Bulletin
language:en
Short-container-title:Brain Research Bulletin

Author:

Broetto Núbia,Hansen Fernanda,Brolese Giovana,Batassini Cristiane,Lirio Franciane,Galland Fabiana,dos Santos João Paulo Almeida,Dutra Márcio Ferreira,Gonçalves Carlos-Alberto

Funder

National Council for Scientific and Technological Development

Publisher

Elsevier BV

Subject

General Neuroscience

Reference54 articles.

1. Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model;Agrawal;Eur. Neuropsychopharmacol.,2011

2. The protein phosphatase inhibitor okadaic acid induces heat shock protein expression and neurodegeneration in rat hippocampus in vivo;Arias;Exp. Neurol.,1998

3. The phosphatase inhibitor okadaic acid, strongly protects primary rat cortical neurons from lethal oxygen-glucose deprivation;Atkinson;Biochem. Biophys. Res. Commun.,2009

4. Green tea (−)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia;Biasibetti;Behav. Brain Res.,2013

5. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models;Brandt;Biochim. Biophys. Acta,2005

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A biomimetic upconversion nanoreactors for near-infrared driven H2 release to inhibit tauopathy in Alzheimer's disease therapy;Bioactive Materials;2024-12

2. Emerging paradigms in Alzheimer's therapy;European Journal of Pharmacology;2024-10

3. Exploring the molecular mechanisms underlying neuroprotective effect of ellagic acid in okadaic acid-induced Alzheimer’s phenotype;Metabolic Brain Disease;2024-08-12

4. Changes in Astroglial Water Flow in the Pre-amyloid Phase of the STZ Model of AD Dementia;Neurochemical Research;2024-05-11

5. Psychoplastogenic DYRK1A Inhibitors with Therapeutic Effects Relevant to Alzheimer’s Disease;Journal of Medicinal Chemistry;2024-04-22